In addition to providing high-dose IL-2 treatment, the Biotherapy Program offers innovative clinical research trials conducted by scientists in the Robert W. Franz Cancer Research Center. The clinical trials available to patients may include one or a combination of these treatments: cancer vaccines; novel chemotherapy approaches; and new medicines to stimulate the immune system, including cell-based and cytokine-based immunotherapy medicines.
Providence Cancer Center also has technology for delivering state-of-the-art care in radiation therapy and surgery. Several nationally recognized medical oncologists, radiation oncologists, surgical oncologists and urologists distinguish our team.
Learn more about Providence Cancer Center's Biotherapy Program:
